Preventive PCI versus only optimal medical therapy for vulnerable plaques
Marc Bonaca, MD
Self-assessment on statin eligibility without prescription using a web app
Steven Nissen, MD
Characteristics of patients with DM using icosapent ethyl in the real world
Om P. Ganda, MD
The effect of icosapent ethyl on CV events in metabolic syndrome
Michael Miller, MD
Loading...
We’re glad to see you’re enjoying PACE-CME…but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.